Details for Patent: 5,002,953

Summary for Patent: 5,002,953

Title:	Novel compounds
Abstract:	Compounds of formula (I): ##STR1## or a tautomeric form thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, wherein: A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6; pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicine.
Inventor(s):	Hindley; Richard M. (Surrey, GB2)
Assignee:	Beecham Group p.l.c. (Brentford, GB2)
Application Number:	07/457,272
Patent Claim Types: see list of patent claims	Compound; Composition; Use;

Drugs Protected by US Patent 5,002,953

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,002,953

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	8720825	Sep 04, 1987
United Kingdom	8727987	Nov 30, 1987
United Kingdom	8802454	Feb 04, 1988

International Family Members for US Patent 5,002,953

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0306228		SPC/GB01/002	United Kingdom
European Patent Office	0306228		2001C/004	Belgium
European Patent Office	0306228		C300034	Netherlands
European Patent Office	0306228		38/2000	Austria
Austria	186724
Australia	2173888